ALPHA MEDICAL SOLUTIONS LIMITED


Directors	WECHALEKAR, Ashutosh, Dr
	WECHALEKAR, Kshama, Dr


Registered Address	1st Floor, Buckley House 31a
	The Hundred
	Romsey
	SO51 8GD


Registered Number	08020065 (England and Wales)

Balance Sheet as at
30 April 2025

	Notes	2025		2024
		£	£	£	£
Fixed assets
Tangible assets	3		91,096		4,242
			91,096		4,242
Current assets
Debtors	4	2,110,871		1,031,180
Cash at bank and on hand		440,699		1,278,826
		2,551,570		2,310,006
Creditors amounts falling due within one year	5	(164,164)		(121,310)
Net current assets (liabilities)			2,387,406		2,188,696
Total assets less current liabilities			2,478,502		2,192,938
Net assets			2,478,502		2,192,938
Capital and reserves
Called up share capital			100		100
Profit and loss account			2,478,402		2,192,838
Shareholders' funds			2,478,502		2,192,938

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 13 January 2026, and are signed on its behalf by:

WECHALEKAR, Ashutosh, Dr
Director
Registered Company No. 08020065

ALPHA MEDICAL SOLUTIONS LIMITED

Notes to the Financial Statements
for the year ended 30 April 2025

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

	Statement of compliance
	The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Going concern
	After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.

	Turnover policy
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

	Foreign currency translation
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

Foreign currency translation

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

	Tangible fixed assets and depreciation
	All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Tangible fixed assets and depreciation

All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:


		Reducing balance (%)
	Fixtures and fittings	25
	Vehicles	25
	Office Equipment	50

2.	Average number of employees


		2025		2024
	Average number of employees during the year	2		2

3.	Tangible fixed assets

	Vehicles	Fixtures & fittings	Office Equipment	Total
	£	£	£	£
Cost or valuation
At 01 May 24	-	9,377	9,150	18,527
Additions	110,335	-	1,686	112,021
At 30 April 25	110,335	9,377	10,836	130,548
Depreciation and impairment
At 01 May 24	-	5,933	8,352	14,285
Charge for year	23,805	862	500	25,167
At 30 April 25	23,805	6,795	8,852	39,452
Net book value
At 30 April 25	86,530	2,582	1,984	91,096
At 30 April 24	-	3,444	798	4,242

4.	Debtors: amounts due within one year

	2025	2024
	£	£
Trade debtors / trade receivables	43,569	58,502
Other debtors	2,067,302	972,678
Total	2,110,871	1,031,180


	Included in other debtors, is a loan made by the Company to Vipradas Investments Limited, a company registered in England & Wales. The directors of Alpha Medical Solutions Limited are also the directors of Vipradas Investments Limited. Interest @ 2.5% is being charged for the loan advanced to Vipradas Investments. As on 30th April 2025, the total amount outstanding (including interest) is £2,061,535.

Included in other debtors, is a loan made by the Company to Vipradas Investments Limited, a company registered in England & Wales. The directors of Alpha Medical Solutions Limited are also the directors of Vipradas Investments Limited. Interest @ 2.5% is being charged for the loan advanced to Vipradas Investments. As on 30th April 2025, the total amount outstanding (including interest) is £2,061,535.

5.	Creditors: amounts due within one year

	2025	2024
	£	£
Trade creditors / trade payables	3,415	233
Taxation and social security	130,958	113,928
Other creditors	26,793	4,151
Accrued liabilities and deferred income	2,998	2,998
Total	164,164	121,310